HIV Progression

Six months after start of treatment could be optimum time for making prognosis

Published in AIDS Weekly, September 15th, 2003

An international study suggests that prognosis for patients with HIV/AIDS might be more reliably determined 6 months after initiation of highly active antiretroviral therapy (HAART), rather than before the start of treatment.

HAART became widespread in more-developed countries from 1996 onward, and has improved the prognosis of HIV-1 infection. However, not enough is known about how to predict the prognosis of people with HIV-1 infection starting HAART.

The initial measurement of specific immune response cells (CD4 cells) and viral load at the time patients start HAART is related to HIV/AIDS progression; in general, the lower the CD4 cell count and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2003-09-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry